SCHEMBL6272567

SCHEMBL6272567

CC(C)=CCc1c2ccoc2c(O)c2oc(=O)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.54
▸ PTGS1 P23219 1/20 0.54
▸ PDE4D Q08499 2/20 0.52
▸ ABCB1 P08183 4/20 0.51
▸ CYP1B1 Q16678 4/20 0.51
▸ CYP1A1 P04798 3/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ XPO1 O14980 2/20 0.48
▸ ALOX5 P09917 1/20 0.48
▸ GABRA1 P14867 1/20 0.48
▸ PTGS2 P35354 1/20 0.48
▸ GABRB2 P47870 1/20 0.48
▸ BACE1 P56817 3/20 0.45
▸ VKORC1 Q9BQB6 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30945593 0.87 PDE4D (0.55) MAOAPTGS1PDE4DABCB1CYP1B1
SCHEMBL16352046 0.79 CYP1B1 (0.69) MAOAPTGS1PDE4DABCB1CYP1B1
SCHEMBL29740208 0.79 CYP1B1 (0.69) MAOAPTGS1PDE4DABCB1CYP1B1
SCHEMBL10319923 0.78 CYP3A4 (0.57) MAOAABCB1CYP1B1CYP1A1CYP1A2
SCHEMBL13532215 0.77 BACE1 (0.57) MAOAPTGS1PDE4DABCB1CYP1B1
SCHEMBL7895128 0.74 CYP3A4 (0.49) MAOAABCB1CYP1B1CYP1A1CYP1A2
SCHEMBL6361059 0.73 CYP3A4 (0.75) MAOAABCB1CYP1B1CYP1A1CYP1A2
SCHEMBL20036257 0.72 CYP1B1 (0.77) PDE4DABCB1CYP1B1CYP1A1CYP1A2
Osthenol SCHEMBL51013 0.71 PTGS1 (1.00) MAOAPTGS1PDE4DABCB1CYP1A2
SCHEMBL31315053 0.70 CYP1B1 (0.88) ABCB1CYP1B1CYP1A1CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115385927-B Separation process and application of furocoumarin natural free radical scavenger in dracocephalum heterophyllum 中国科学院西北高原生物研究所 2024-06-25 — — CN claimed
CN-118141711-A Refined crocodile lithospermum oil and extraction method thereof 广州钛利实业控股有限公司 2024-06-07 — — CN claimed
EP-3281626-B1 SOLUBLE MICRONEEDLE FOR DELIVERING POORLY-SOLUBLE DRUG LG HOUSEHOLD & HEALTH CARE LTD (KR) 2023-08-23 — — EP claimed
US-12507703-B2 Methods, devices and compositions for preserving human milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-12-30 — — US disclosed
CN-121129833-A Coumarin compounds suitable for inhibiting cell death and application thereof 上海中医药大学附属龙华医院 2025-12-16 — — CN disclosed
CN-120392744-A Use of Alloimperatorin in preparing antiviral medicine 山东师范大学 2025-08-01 — — CN disclosed
CN-120392744-A Use of Alloimperatorin in preparing antiviral medicine 山东师范大学 2025-08-01 — — CN disclosed
US-20250169516-A1 METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-05-29 — — US disclosed
CN-119925442-A Application of radix angelicae extract in preparation of aquatic pathogenic bacteria resistant medicines or feed additives 西安九清医疗科技有限公司 2025-05-06 — — CN disclosed
CN-119770584-A Traditional Chinese medicine composition and traditional Chinese medicine preparation for clearing heat from throat and preparation method and application thereof 吉林大学 2025-04-08 — — CN disclosed
US-12239142-B2 Methods, devices and compositions for preserving human milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-03-04 — — US disclosed
US-11577064-B2 Method and device for manufacturing microneedle having coating part on tip thereof LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2023-02-14 — — US disclosed
CN-115671096-A Application of 6-methoxy angelicin and structural analogue thereof 西北工业大学 2023-02-03 — — CN disclosed
CN-110846159-A Antibacterial and bacteriostatic soap composition and prepared soap 上海制皂有限公司 2020-02-28 — — CN disclosed
US-20090233997-A1 COMPOSITION FOR PROMOTING SYNTHESIS OF COLLAGEN, AND COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN COMPRISING THE SAME LG HOUSEHOLD & HEALTH CARE, LTD. (KR) 2009-09-17 — — US disclosed
US-20090233997-A1 COMPOSITION FOR PROMOTING SYNTHESIS OF COLLAGEN, AND COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN COMPRISING THE SAME LG HOUSEHOLD & HEALTH CARE, LTD. (KR) 2009-09-17 — — US disclosed
US-20070065377-A1 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2007-03-22 — — US disclosed
US-20070065377-A1 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2007-03-22 — — US disclosed
WO-2005095415-A1 PROCESS FOR ISOLATION OF IMPERATORIN FROM AEGLE MARMELOS CORREA COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-10-13 — — WO disclosed
US-20050220913-A1 Novel in-expensive and efficient process for isolation of imperatorin, a potent inducible nitric oxide synthase inhibitor and anti-inflammatory drug candidate from Aegle marmelos Correa COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2005-10-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233997-A1 COMPOSITION FOR PROMOTING SYNTHESIS OF COLLAGEN, AND COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN COMPRISING THE SAME COL14A1, COL2A1, COL1A1 MAOA 2518/4885PTGS1 470/4885PDE4D 2454/4885
US-20070065377-A1 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same COL14A1, COL2A1, COL1A1 MAOA 2518/4885PTGS1 470/4885PDE4D 2454/4885
US-12507703-B2 Methods, devices and compositions for preserving human milk LPL, CEL, LPO MAOA 471/4885PTGS1 4638/4885PDE4D 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback